From owner-drosophila@net.bio.net Mon Mar 04 22:00:00 1996
Path: biosci!bcm.tmc.edu!usenet
From: Andrea Marie Peier <ap691301@bcm.tmc.edu>
Newsgroups: bionet.drosophila
Subject: EMS mutagenesis
Date: Mon, 04 Mar 1996 18:39:39 -0600
Organization: Baylor College of Medicine, Houston, Tx
Lines: 9
Message-ID: <313B8D4B.41C67EA6@bcm.tmc.edu>
NNTP-Posting-Host: kiwi.imgen.bcm.tmc.edu
Mime-Version: 1.0
Content-Type: text/plain; charset=us-ascii
Content-Transfer-Encoding: 7bit
NNTP-Posting-User: ap691301
X-Mailer: Mozilla 2.0 (X11; I; SunOS 4.1.3_U1 sun4m)

Why does sperm storage (treated with alkylating agents such as EMS) in
females effect the types of mutations recovered. Ashburner states that
when sperm treated with EMS are stored in the female reproductive tract,
there is an increase in the number of chromosome aberrations recovered
vs. point mutations. I'm not exactly clear why . Can someone explain it
to me?

Best regards,
Andrea

.